RecruitingNCT07319442
CEDUR - German IBD Registry
Long-term Observation of IBD Patients, a Nationwide German IBD Registry "CEDUR"
Sponsor
ImmunoRegister gUG
Enrollment
10,000 participants
Start Date
May 3, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
The CEDUR registry systematically collects real-world data on inflammatory bowel disease (IBD) patients in Germany. The registry aims to assess quality of care, disease activity, treatment effectiveness, safety, and pharmacoeconomic aspects under routine clinical conditions.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Crohn Disease Ulcerative Colitis Indterminate Colitis
Exclusion Criteria1
- Other gastrointestinal disorders than above
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07319442
Related Trials
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
NCT072375165 locations
Prospective Evaluation of the Carbon Footprint and Clinical Utility of IBUS Compared to Colonoscopy and Enterography in UC and CD
NCT074319832 locations
Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis
NCT0727106917 locations
Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease
NCT073005531 location
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
NCT0711352266 locations